Download Library

Title Documents

View Form 8937 - January 7, 2015

View Form 8937 - July 15, 2014

Theravance, Inc. Addendum to Conflict of Interest Policy
with Regard to Theravance Biopharma, Inc. Matters

Audit Committee Charter

Comprehensive Compliance Program and Declaration

Science and Technology Advisory Committee Charter.

Bylaws

Compensation Committee Charter

Nominating & Corporate Governance Committee Charter

Copyright West LLC. Minimum 15 minutes delayed.

Contact

Toll-Free
877-202-1097

Innoviva Investor Relations & Media
Sloane and Company
212-446-9500

For business development inquiries,
please contact investor.relations@inva.com.